[ 1 ] Rudolph AM. Congenital Diseases of the heart: clinical-physiological considerations[M]. 3rd ed. West Sussex: John Wiley & Sons Ltd, 2009: 148-178.
[2]
[ 2 ] Anderson RH, Wilcox BR. The surgical anatomy of ventricular septal defects[J]. J Card Surg, 1992, 7(1): 17-35.
[3]
[ 3 ] Tweddell JS, Pelech AN, Frommelt PC. Ventricular septal defect and aortic valve regurgitation: pathophysiology and indications for surgery[J]. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 2006, 9(1): 147-152.
[4]
[ 4 ] de Leval MR, Pozzi M, Starnes V, et al. Surgical management of doubly committed subarterial ventricular septal defects[J]. Circulation, 1988, 78 (5 Pt 2): Ⅲ 40-46.
[ 6 ] Gan C, An Q, Lin K, et al. Perventricular device closure of ventricular septal defects: six months results in 30 young children[J]. Ann Thorac Surg, 2008, 86(1): 142-146.
[7]
[ 9 ] Lê TP, Vaessen P, Freudenthal F, et al. Transcatheter closure of subaortic ventricular septal defect (VSD) using a nickel-titanium spiral coil (NitOcclud): animal study and initial clinical results[J]. Prog Ped Cardio, 2001, 14(1): 83-88.
[8]
Sim EKW, Grignani RT, Wong ML, et al. Outcome of surgical closure of doubly committed subarterial ventricular septal defect[J]. Ann Thorac Surg, 1999, 67(3): 736-738.
[9]
Moodie DS. Technology insight: transcatheter closure of ventricular septal defects[J]. Nat Clin Pract Cardiovasc Med, 2005, 2(11): 592-596.
[10]
Gu M, You X, Zhao X, et al. Transcatheter device closure of intracristal ventricular septal defects[J]. Am J Cardiol, 2011, 107(1): 110-113.
[11]
Fu YC, Bass J, Amin Z, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial[J]. JACC, 2006, 47(2): 319-325.
[12]
Zhou T, Shen XQ, Zhou SH, et al. Atrioventricular block: a serious complication in and after transcatheter closure of perimembranous ventricular septal defects[J]. Clinical Cardiology, 2008, 31(8): 368-371.
[13]
Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect[J]. Catheter Cardiovasc Interv, 2005, 66(3): 436-441.
[14]
[ 7 ] Lock JE, Block PC, McKay RG, et al. Transcatheter closure of ventricular septal defects[J]. Circulation, 1988, 78(2): 361-368.
[15]
[ 8 ] Szkutnik M, Qureshi SA, Kusa J, et al. Use of the amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects[J]. Heart, 2007, 93(3): 355-358.
